Hrt Financial »

Halozyme Therapeutics shares owned by Hrt Financial

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Hrt Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.9M 78k 36.95
2023-09-30 $3.1M 82k 38.19
2023-06-30 $1.1M 32k 36.06
2023-03-31 $2.8M 74k 38.18
2022-12-31 $3.6M 63k 56.89
2022-09-30 $701k 18k 39.50
2022-06-30 $3.4M 78k 43.99
2021-12-31 $1.4M 36k 40.20
2021-03-31 $879k 21k 41.67
2019-12-31 $244k 14k 17.70
2019-09-30 $319k 21k 15.48